Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RA2159 | Lestaurtinib | 0.3 | uM | 1 | IL-2 | 39.0 | 71 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 1 | IL-2 | 38.0 | 70 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 1 | IL-2 | 39.0 | 84 | ||||
| RA2159 | IKK16 | 2.0 | uM | 1 | IL-2 | 39.0 | 69 | ||||
| RA2159 | 1 | IL-2 | 38.0 | 73 | |||||||
| N2586 | 1 | IL-2 | 35.0 | 73 | |||||||
| N2586 | PD184352 | 0.1 | uM | 1 | IL-2 | 33.0 | 77 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 1 | IL-2 | 35.0 | 65 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 1 | IL-2 | 30.0 | 75 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 1 | IL-2 | 39.0 | 73 | ||||
| N2586 | IKK16 | 2.0 | uM | 1 | IL-2 | 36.0 | 89 | ||||
| N2586 | 1 | IL-2 | 37.0 | 73 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 1 | IL-2 | 37.0 | 57 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 36.5 | 76 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 40.0 | 73 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 39.0 | 81 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 39.0 | 63 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 31.0 | 68 | |
| N2586 | Visfatin | 1 | ng/mL | 1 | IL-2 | 34.5 | 94 | ||||
| N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 39.0 | 80 | |
| N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 39.0 | 87 | |
| N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 30.0 | 79 | |
| N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 33.0 | 63 | |
| N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-2 | 38.0 | 33 | |
| 0 | IL-2 | 35.5 | 74 |